These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1839553)

  • 1. Prevention of perinatal transmission of hepatitis B virus (HBV): a comparison of two prophylactic schedules.
    Wheeley SM; Jackson PT; Boxall EH; Tarlow MJ; Gatrad AR; Anderson J; Bissenden J
    J Med Virol; 1991 Nov; 35(3):212-5. PubMed ID: 1839553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg.
    Pongpipat D; Suvatte V; Assateerawatts A
    Asian Pac J Allergy Immunol; 1986 Jun; 4(1):33-6. PubMed ID: 3730058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.
    Eke AC; Eleje GU; Eke UA; Xia Y; Liu J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008545. PubMed ID: 28188612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoprophylaxis of perinatal transmission of the hepatitis B virus: efficacy of hepatitis B immune globulin and hepatitis B vaccine in a low-prevalence area.
    Esteban JI; Genesca J; Esteban R; Hernandez JM; Seijo G; Buti M; Muniz R; Guardia J
    J Med Virol; 1986 Apr; 18(4):381-91. PubMed ID: 2940334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA.
    Ip HM; Lelie PN; Wong VC; Kuhns MC; Reesink HW
    Lancet; 1989 Feb; 1(8635):406-10. PubMed ID: 2563788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand.
    Lolekha S; Warachit B; Hirunyachote A; Bowonkiratikachorn P; West DJ; Poerschke G
    Vaccine; 2002 Nov; 20(31-32):3739-43. PubMed ID: 12399203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
    Yin YZ; Zhou J; Zhang PZ; Hou HY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
    Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
    Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B.
    Grosheide PM; del Canho R; Voogd M; Heijtink RA; Schalm SW
    Vaccine; 1994 Sep; 12(12):1059-63. PubMed ID: 7998413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan.
    Yang YJ; Liu CC; Chen TJ; Lee MF; Chen SH; Shih HH; Chang MH
    Pediatr Infect Dis J; 2003 Jul; 22(7):584-8. PubMed ID: 12867831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.
    Wang Z; Zhang J; Yang H; Li X; Wen S; Guo Y; Sun J; Hou J
    J Med Virol; 2003 Nov; 71(3):360-6. PubMed ID: 12966540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B immunization in high risk neonates born from HBsAg and HBeAg positive mothers: comparison of standard and low dose regimens.
    Pongpipat D; Suvatte V; Assateerawatts A
    Asian Pac J Allergy Immunol; 1988 Dec; 6(2):107-10. PubMed ID: 2975491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter trial on the efficacy of HBIG and vaccine in preventing perinatal hepatitis B. Final report.
    Zanetti AR; Dentico P; Del Vecchio Blanco C; Sagnelli E; Villa E; Ferroni P; Bergamini F
    J Med Virol; 1986 Apr; 18(4):327-34. PubMed ID: 2940333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B vaccine alone or in combination with anti-HBs immunoglobulin in the perinatal prophylaxis of babies born to HBsAg carrier mothers.
    Sehgal A; Gupta I; Sehgal R; Ganguly NK
    Acta Virol; 1992 Aug; 36(4):359-66. PubMed ID: 1362320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between the HBsAg-positive infection status of mothers and the non/low-response to hepatitis B vaccine of their infants].
    Yang ZQ; Hao HY; Shi XH; Fu ZD; Zhang F; Wang XF; Xu XX; Wang B; Wen HX; Feng SY; Wang B; Wang SP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):805-809. PubMed ID: 29936751
    [No Abstract]   [Full Text] [Related]  

  • 17. A retrospective study of hepatitis B mother-to-child transmission prevention and postvaccination serological test results of infants at risk of perinatal transmission in two counties of middle China.
    Yonghao G; Pumei D; Jianhui Y; Jin X; Yanyang Z; Zhe W
    J Viral Hepat; 2017 Aug; 24(8):687-695. PubMed ID: 28199772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.
    Zhang L; Gui XE; Wang B; Fan JY; Cao Q; Mullane K; Liang XL
    BMC Infect Dis; 2016 Aug; 16(1):408. PubMed ID: 27515176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B immunoglobulin (HBIG) efficacy in the prevention of perinatal transmission of hepatitis B virus (HBV) infection.
    Ichida F; Yoshikawa A; Tokunaga A; Takeuchi S
    Gastroenterol Jpn; 1983 Feb; 18(1):56-9. PubMed ID: 6832550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.
    Wong VC; Ip HM; Reesink HW; Lelie PN; Reerink-Brongers EE; Yeung CY; Ma HK
    Lancet; 1984 Apr; 1(8383):921-6. PubMed ID: 6143868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.